Stockscreener 앱 받기
14.25
1.06%
0.15
Pulse Biosciences Inc 주식(PLSE)의 최신 뉴스
Trading the Move, Not the Narrative: (PLSE) Edition - Stock Traders Daily
Dividend Watch: Is Pulse Biosciences Inc stock influenced by commodity pricesJuly 2025 Breakouts & AI Driven Price Forecasts - baoquankhu1.vn
Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 1.4%Here's What Happened - MarketBeat
Pulse Biosciences Nabs FDA IDE Approval for nPulse Cardiac Catheter Ablation System Study - Medical Product Outsourcing
Pulse Biosciences updates investor deck on cardiac pipeline - TipRanks
Pulse Biosciences, Inc. Updates Investor Presentation - TradingView — Track All Markets
Earnings Miss: Is Pulse Biosciences Inc. exposed to currency risksWeekly Stock Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Analyst Calls: Is Pulse Biosciences Inc stock recession proof2025 Earnings Impact & Daily Profit Focused Screening - Bộ Nội Vụ
Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring A 51% Potential Upside - DirectorsTalk Interviews
New Cardiac Ablation Data and Board Appointment Might Change The Case For Investing In Pulse Biosciences (PLSE) - simplywall.st
How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh - Yahoo Finance
How buybacks impact Pulse Biosciences Inc. stock valueEarnings Recap Summary & Free Verified High Yield Trade Plans - Улправда
Will Pulse Biosciences Inc. stock outperform tech sector in 20252025 Geopolitical Influence & Verified Trade Idea Suggestions - Улправда
Will Pulse Biosciences Inc. (6L8) stock profit from automation wave2025 Key Highlights & Entry Point Confirmation Signals - ulpravda.ru
Pulse Biosciences appoints healthcare veteran Maria Sainz to board By Investing.com - Investing.com Nigeria
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors - 01net
Pulse Biosciences Adds Veteran Healthtech Leader to Board - TipRanks
Pulse Biosciences Elects Maria Sainz to Board of Directors - TradingView — Track All Markets
Pulse Biosciences appoints healthcare veteran Maria Sainz to board - Investing.com
Can Pulse Biosciences Inc. stock continue upward trendPortfolio Performance Summary & Growth Focused Entry Reports - ulpravda.ru
Weekly Earnings: Will Pulse Biosciences Inc. (6L8) stock outperform value peersEarnings Overview Summary & Growth Focused Entry Reports - Улправда
Will Pulse Biosciences Inc. stock reach Wall Street targetsMarket Trend Review & Real-Time Volume Trigger Notifications - Улправда
Is MBX Biosciences Inc. stock positioned well for digital economyJuly 2025 Short Interest & Safe Entry Momentum Tips - Улправда
Why Pulse Biosciences Inc. stock remains resilient2025 Key Lessons & Daily Stock Momentum Reports - Улправда
Can Pulse Biosciences Inc. (6L8) stock deliver double digit returnsMarket Weekly Review & Safe Capital Allocation Plans - Улправда
Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium - Bluefield Daily Telegraph
(PLSE) Volatility Zones as Tactical Triggers - Stock Traders Daily
Working capital per share of Pulse Biosciences, Inc. – DUS:6L8 - TradingView — Track All Markets
What analysts say about Pulse Biosciences Inc 6L8 stockEarnings Growth Projections & Test Our Stock Screener — Free Forever - Early Times
Value Recap: Is The E.W. Scripps Company stock a buy in volatile marketsLong Setup & Daily Market Momentum Tracking - moha.gov.vn
Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Bluefield Daily Telegraph
Total debt per share of Pulse Biosciences, Inc. – MUN:6L8 - TradingView — Track All Markets
Positron (OTCMKTS:POSC) vs. Pulse Biosciences (NASDAQ:PLSE) Critical Comparison - Defense World
What drives Pulse Biosciences Inc 6L8 stock priceHigh Dividend Yield Stocks & High Profit Market Growth - earlytimes.in
MSN Money - MSN
Understanding the Setup: (PLSE) and Scalable Risk - Stock Traders Daily
Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial - Sahm
Pulse Biosciences Updates Investors on Product Advancements - MSN
Pulse Biosciences, Inc (PLSE) Investor Outlook: Exploring A 44.74% Potential Upside - DirectorsTalk Interviews
Why Pulse Biosciences (PLSE) Is Up 8.0% After FDA Clears Pivotal Atrial Fibrillation Trial - Sahm
Pulse Biosciences holds 2025 annual stockholder meeting - MSN
Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans - Sahm
Can Pulse Biosciences Inc. stock beat market expectations this quarterEarnings Recap Report & Growth Focused Stock Reports - Улправда
What technical signals suggest for Pulse Biosciences Inc. stockSell Signal & AI Driven Price Forecasts - Улправда
Pulse Biosciences announces inducement grants under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Market Pulse: How Aura Biosciences Inc. stock performs in high volatility marketsWall Street Watch & Long-Term Safe Investment Ideas - Улправда
Aug Fed Impact: Can Pulse Biosciences Inc. (6L8) stock deliver double digit returnsQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - Улправда
PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial - sharewise.com
How Pulse Biosciences Inc. stock responds to policy changesMarket Risk Summary & Daily Risk Controlled Trade Plans - DonanımHaber
Can Pulse Biosciences Inc. stock resist market sell offs2025 Support & Resistance & Community Verified Trade Signals - DonanımHaber
FDA approves Pulse Biosciences’ atrial fibrillation trial By Investing.com - Investing.com Australia
How Pulse Biosciences Inc. stock benefits from tech adoptionMarket Sentiment Report & Consistent Profit Trading Strategies - DonanımHaber
0.01%
1.19%
자본화:
|
볼륨(24시간):